Myeloperoxidase level and inflammatory markers and lipid and lipoprotein parameters in stable coronary artery disease

被引：0
|
作者：
Elżbieta Kimak
Bartosz Zięba
Dariusz Duma
Janusz Solski
机构：
[1] Medical University,Department of Laboratory Diagnostics
[2] Department of Cardiology of the Provincial Specialistics Cardinal Stefan Wyszynski Hospital,undefined
来源：
Lipids in Health and Disease | / 17卷
关键词：
Myeloperoxidase; Inflammatory markers; Lipids; Lipoproteins; Stable coronary;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Correlation of lipoprotein (a) concentration with the extent of coronary artery disease in patients on lipid lowering therapy
    Malek, Filip
    Dvorak, Jan
    Svitil, Jan
    Skalnikova, Vladimira
    Mates, Martin
    Kmonicek, Petr
    Formanek, Pavel
    Aschermann, Ondrej
    Kopriva, Karel
    Nuzil, Petr
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 : 55 - 59
  • [22] Liberation of vessel-adherent myeloperoxidase reflects plaque burden in patients with stable coronary artery disease
    Rudolph, Tanja K.
    Schaper, Neele
    Klinke, Anna
    Demir, Cagri
    Goldmann, Britta
    Lau, Denise
    Koester, Ralf
    Hellmich, Martin
    Meinertz, Thomas
    Baldus, Stephan
    Rudolph, Volker
    ATHEROSCLEROSIS, 2013, 231 (02) : 354 - 358
  • [23] Trans-vessel gradient of myeloperoxidase in coronary artery disease
    Alipour, Arash
    Ribalta, Josep
    Njo, Tjin L.
    Janssen, Hans W.
    Birnie, Erwin
    van Miltenburg, Addy J. M.
    Elte, Jan Willem F.
    Cabezas, Manuel Castro
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2013, 43 (09) : 920 - 925
  • [24] Inflammatory markers in coronary heart disease
    Madjid, Mohammad
    Willerson, James T.
    BRITISH MEDICAL BULLETIN, 2011, 100 (01) : 23 - 38
  • [25] Biomarkers in Stable Coronary Artery Disease
    Rusnak, Jonas
    Fastner, Christian
    Behnes, Michael
    Mashayekhi, Kambis
    Borggrefe, Martin
    Akin, Ibrahim
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2017, 18 (06) : 456 - 471
  • [26] Inflammatory markers and coronary heart disease
    Rifai, N
    Ridker, PM
    CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (04) : 383 - 389
  • [27] Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease
    Schlitt, A
    Blankenberg, S
    Bickel, C
    Meyer, J
    Hafner, G
    Jiang, XC
    Rupprecht, HJ
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 102 (03) : 477 - 485
  • [28] FAMILIAL LIPOPROTEIN DISORDERS IN PATIENTS WITH PREMATURE CORONARY-ARTERY DISEASE
    GENEST, JJ
    MARTINMUNLEY, SS
    MCNAMARA, JR
    ORDOVAS, JM
    JENNER, J
    MYERS, RH
    SILBERMAN, SR
    WILSON, PWF
    SALEM, DN
    SCHAEFER, EJ
    CIRCULATION, 1992, 85 (06) : 2025 - 2033
  • [29] Serum lipoprotein lipase concentration and risk for future coronary artery disease
    Rip, J
    Nierman, MC
    Wareham, NJ
    Luben, R
    Bingham, SA
    Day, NE
    van Miert, JNI
    Hutten, BA
    Kastelein, JJP
    Kuivenhoven, JA
    Khaw, KT
    Boekholdt, SM
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (03) : 637 - 642
  • [30] Triglyceride enriched lipoprotein particles correlate with the severity of coronary artery disease
    Koren, E
    Corder, C
    Mueller, G
    Centurion, H
    Hallum, G
    Fesmire, J
    McConathy, WD
    Alaupovic, P
    ATHEROSCLEROSIS, 1996, 122 (01) : 105 - 115
12345